A Clinical Trial to Explore the Safety and Efficacy of CT071 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Primary Plasma Cell Leukemia

Study Summary

A Clinical Trial to Explore the Safety and Efficacy of CT071 injection in Patients with Relapsed/Refractory Multiple Myeloma or Primary Plasma Cell Leukemia

Interventions

Study Locations

Facility	City	State	Country
Shanghai Changzheng Hospital	Shanghai		China

Official Trial Information

View on ClinicalTrials.gov